Summary Box: Amgen CEO sees higher gross revenue in 2012 Sacramento hymenopteran MOMENTUM: Positive developments consider last year's purchase of a cancer vaccine developer and moves to protect long-term sales of apical seller Enbrel, for disease of the skin and rheumatoid arthritis, and anemia treatment Epogen. social control MOVES: Along with ... Next Amgen CEO sees more markets, higher gross revenue Los Angeles Times each 147 news articles » Link To Article
No comments:
Post a Comment